Home Investors RA Capital

RA Capital

Active VC

Portfolio Active

1

Latest Alchemab Therapeutics

Deal flow

$32M

1 round

Unicorns

0

≥ $1B valuation

Founded

—

Latest

—

Alchemab Therapeutics

About RA Capital

Venture capital firm tracking 1 AI investment, with focus on Drug Discovery. Total tracked deal flow: $32M.

Sector focus

💊 Drug Discovery 1

Portfolio

1

Alchemab Therapeutics

UK biotech using machine learning to mine patient-derived immune responses for protective

Co-investors

5

Lightstone Ventures

DCVC Bio

SV Health Investors

Ono Venture Investment

Eli Lilly

Recent rounds

1

Series A $32M Alchemab Therapeutics